US Stock MarketDetailed Quotes

CRGX CARGO Therapeutics

Watchlist

16.870
+1.040+6.57%

Close Jul 22 16:00 ET

18.090
+1.220+7.23%

Post 19:45 ET

773.69MMarket Cap-5479P/E (TTM)

CARGO Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

167.63%40.81M

178.13%96.71M

217.64%34.96M

185.71%28.71M

17.8M

15.25M

481.75%34.77M

11.01M

10.05M

5.98M

Selling and administrative expenses

283.72%10.3M

287.53%20.92M

344.70%7.89M

310.00%6.48M

--3.87M

--2.69M

256.07%5.4M

--1.77M

--1.58M

--1.52M

-General and administrative expense

283.72%10.3M

287.53%20.92M

344.70%7.89M

310.00%6.48M

--3.87M

--2.69M

256.07%5.4M

--1.77M

--1.58M

--1.52M

Research and development costs

142.82%30.5M

158.03%75.79M

193.22%27.07M

162.52%22.23M

--13.93M

--12.56M

558.44%29.37M

--9.23M

--8.47M

--4.46M

Operating profit

-167.63%-40.81M

-178.13%-96.71M

-217.64%-34.96M

-185.71%-28.71M

-17.8M

-15.25M

-481.75%-34.77M

-11.01M

-10.05M

-5.98M

Net non-operating interest income expense

433.89%5.01M

67.54%-1.6M

-105K

-1.5M

-4.94M

-2.71M

-1.46M

Non-operating interest income

4,666.67%5.01M

----

--105K

----

Non-operating interest expense

--0

-67.54%1.6M

--0

--1.6M

--4.94M

--2.71M

--1.46M

--0

Other net income (expense)

-100.25%-10K

113.49%167K

8,097.22%2.88M

-768.89%-6.76M

49K

-1,074.80%-1.24M

-36K

-778K

127K

Gain on sale of security

----

630.67%6.45M

--0

----

--0

--6.45M

---1.22M

---30K

---779K

----

Special income (charges)

--0

---2.32M

--0

---2.32M

--0

----

-Less:Other special charges

----

--2.32M

--0

----

--0

--2.32M

----

Other non- operating income (expenses)

92.75%-10K

-17,945.45%-3.97M

48,083.33%2.88M

-676,100.00%-6.76M

--49K

---138K

-117.32%-22K

---6K

--1K

--127K

Income before tax

-180.94%-35.81M

-139.67%-98.15M

-133.30%-32.08M

-188.73%-35.47M

-17.85M

-12.75M

-600.02%-40.95M

-13.75M

-12.29M

-5.85M

Income tax

Net income

-180.94%-35.81M

-139.67%-98.15M

-133.30%-32.08M

-188.73%-35.47M

-17.85M

-12.75M

-600.02%-40.95M

-13.75M

-12.29M

-5.85M

Net income continuous Operations

-180.94%-35.81M

-139.67%-98.15M

-133.30%-32.08M

-188.73%-35.47M

---17.85M

---12.75M

-600.02%-40.95M

---13.75M

---12.29M

---5.85M

Minority interest income

Net income attributable to the parent company

-180.94%-35.81M

-139.67%-98.15M

-133.30%-32.08M

-188.73%-35.47M

-17.85M

-12.75M

-600.02%-40.95M

-13.75M

-12.29M

-5.85M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-180.94%-35.81M

-139.67%-98.15M

-133.30%-32.08M

-188.73%-35.47M

-17.85M

-12.75M

-600.02%-40.95M

-13.75M

-12.29M

-5.85M

Basic earnings per share

-163.95%-0.87

-685.96%-16.53

-10.25%-0.7785

-45.37%-0.9172

-0.4616

-0.3296

-600.02%-2.1032

-0.7061

-0.6309

-0.3004

Diluted earnings per share

-163.95%-0.87

-685.96%-16.53

-10.25%-0.7785

-45.37%-0.9172

-0.4616

-0.3296

-600.02%-2.1032

-0.7061

-0.6309

-0.3004

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	167.63%40.81M	178.13%96.71M	217.64%34.96M	185.71%28.71M	17.8M	15.25M	481.75%34.77M	11.01M	10.05M	5.98M
Selling and administrative expenses	283.72%10.3M	287.53%20.92M	344.70%7.89M	310.00%6.48M	--3.87M	--2.69M	256.07%5.4M	--1.77M	--1.58M	--1.52M
-General and administrative expense	283.72%10.3M	287.53%20.92M	344.70%7.89M	310.00%6.48M	--3.87M	--2.69M	256.07%5.4M	--1.77M	--1.58M	--1.52M
Research and development costs	142.82%30.5M	158.03%75.79M	193.22%27.07M	162.52%22.23M	--13.93M	--12.56M	558.44%29.37M	--9.23M	--8.47M	--4.46M
Operating profit	-167.63%-40.81M	-178.13%-96.71M	-217.64%-34.96M	-185.71%-28.71M	-17.8M	-15.25M	-481.75%-34.77M	-11.01M	-10.05M	-5.98M
Net non-operating interest income expense	433.89%5.01M	67.54%-1.6M	0	0	-105K	-1.5M	-4.94M	-2.71M	-1.46M	0
Non-operating interest income	4,666.67%5.01M	----	----	----	----	--105K	----	----	----	----
Non-operating interest expense	--0	-67.54%1.6M	--0	--0	--0	--1.6M	--4.94M	--2.71M	--1.46M	--0
Other net income (expense)	-100.25%-10K	113.49%167K	8,097.22%2.88M	-768.89%-6.76M	49K	4M	-1,074.80%-1.24M	-36K	-778K	127K
Gain on sale of security	----	630.67%6.45M	--0	----	--0	--6.45M	---1.22M	---30K	---779K	----
Special income (charges)	--0	---2.32M	--0	--0	--0	---2.32M	--0	--0	--0	----
-Less:Other special charges	----	--2.32M	--0	----	--0	--2.32M	----	----	----	----
Other non- operating income (expenses)	92.75%-10K	-17,945.45%-3.97M	48,083.33%2.88M	-676,100.00%-6.76M	--49K	---138K	-117.32%-22K	---6K	--1K	--127K
Income before tax	-180.94%-35.81M	-139.67%-98.15M	-133.30%-32.08M	-188.73%-35.47M	-17.85M	-12.75M	-600.02%-40.95M	-13.75M	-12.29M	-5.85M
Income tax
Net income	-180.94%-35.81M	-139.67%-98.15M	-133.30%-32.08M	-188.73%-35.47M	-17.85M	-12.75M	-600.02%-40.95M	-13.75M	-12.29M	-5.85M
Net income continuous Operations	-180.94%-35.81M	-139.67%-98.15M	-133.30%-32.08M	-188.73%-35.47M	---17.85M	---12.75M	-600.02%-40.95M	---13.75M	---12.29M	---5.85M
Minority interest income
Net income attributable to the parent company	-180.94%-35.81M	-139.67%-98.15M	-133.30%-32.08M	-188.73%-35.47M	-17.85M	-12.75M	-600.02%-40.95M	-13.75M	-12.29M	-5.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-180.94%-35.81M	-139.67%-98.15M	-133.30%-32.08M	-188.73%-35.47M	-17.85M	-12.75M	-600.02%-40.95M	-13.75M	-12.29M	-5.85M
Basic earnings per share	-163.95%-0.87	-685.96%-16.53	-10.25%-0.7785	-45.37%-0.9172	-0.4616	-0.3296	-600.02%-2.1032	-0.7061	-0.6309	-0.3004
Diluted earnings per share	-163.95%-0.87	-685.96%-16.53	-10.25%-0.7785	-45.37%-0.9172	-0.4616	-0.3296	-600.02%-2.1032	-0.7061	-0.6309	-0.3004
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall